Literature DB >> 7805930

Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols.

J Van der Elst1, M Camus, E Van den Abbeel, R Maes, P Devroey, A C Van Steirteghem.   

Abstract

OBJECTIVE: To investigate the optimal protocol for cryopreservation of human embryos obtained from IVF.
DESIGN: Prospective randomized study.
SETTING: Consenting patients in an academic research environment. PATIENTS: Couples undergoing IVF.
INTERVENTIONS: A cohort of 2,220 supernumerary multicellular embryos were obtained from 488 patients who were randomized over slow freezing protocols with dimethylsulfoxide (DMSO, 819 embryos), 1,2-propanediol (699 embryos) or a mixture of DMSO and 1,2-propanediol (702 embryos). A total of 725 embryos have been thawed (DMSO, 232 embryos; 1,2-propanediol, 250 embryos and DMSO and 1,2-propanediol, 243 embryos) for transfer in natural ovarian cycles. MAIN OUTCOME MEASURES: Embryo survival rate, embryo implantation rate, clinical pregnancy rate (PR), delivery rate, live-birth rate.
RESULTS: The embryo survival rate was significantly higher with the DMSO protocol (52.6%) than with the 1,2-propanediol (32.0%) or the DMSO and 1,2-propanediol protocols (34.9%). The clinical PR per thawing cycle was significantly higher in the DMSO protocol (17.2%) than in the 1,2-propanediol protocol (3.9%). The clinical implantation rate per embryo thawed was significantly different between a DMSO-frozen embryo (4.7%) and a 1,2-propanediol-frozen embryo (1.2%). A DMSO and 1,2-propanediol-frozen embryo had a 3.7% chance of of implantation. The delivery rate per thawing cycle was significantly higher in the DMSO protocol (12.5%) than in the 1,2-propanediol protocol (2.6%). The live-birth rates per embryo thawed were 3.5%, 0.8%, and 2.9% in the DMSO, 1,2-propanediol, and DMSO and 1,2-propanediol groups, respectively.
CONCLUSION: Supernumerary multicellular embryos as presented in daily clinical IVF practice have the highest chance of survival and of implantation after cryopreservation when DMSO has been used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805930

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Comparison of pregnancy outcome of pronuclear- and multicellular-stage frozen-thawed embryo transfers.

Authors:  S Kattera; P Shrivastav; I Craft
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

2.  Effect of Vero cell coculture on the development of frozen-thawed two-cell mouse embryos.

Authors:  N Nematollahi; M R Valojerdi
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

3.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

Review 4.  Review: preimplantation diagnosis of inherited disease.

Authors:  W Lissens; K Sermon; C Staessen; E V Assche; C Janssenswillen; H Joris; A Van Steirteghem; I Liebaers
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  A pragmatic RCT of conventional versus increased concentration sucrose in freezing and thawing solutions for human embryos.

Authors:  M J Wood; J Mollison; K Harrild; E Ferguson; T McKay; A Srikantharajah; L Bell; S Bhattacharya
Journal:  Hum Reprod       Date:  2011-05-16       Impact factor: 6.918

6.  Chromosome abnormalities and viability of vitrified eight-cell mouse embryos at presence of two different cryoprotectants at different storage durations.

Authors:  Shabnam Zarei Moradi; Anahita Mohseni Meybodi; Hamid Gourabi; Hossein Mozdarani; Zahra Mansouri
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.